Apr 4, 20221 minCEO - Dror Chevion, gives Keynote speech and awarded Health 2.0 Outstanding Leadership Award (Dubai)CEO Dror Chevion gave a KEYNOTE speech at the Health 2.0 Conference which attempts to reimagine the realm of healthcare by uniting some...
Jan 30, 20222 min"First-In-Man Clinical Trial – Zygosid-50 for treating T2D" - summary of results (partial)The primary efficacy objective of the study was to demonstrate that treatment with Zygosid-50 yields a significant reduction in the...
May 24, 20211 minOur CLINICAL TRIAL is now Recruiting Type 2 Diabetes PatientsConcenter Biopharma, together with the SHEBA Medical Center in Israel recently began recruiting patients for the clinical trial using the...